Stylus Medicine is on a quest to create disease-treating agents for the next generation based on the groundbreaking work of its founders.
Stylus Medicine has raised $85.0M in total funding. The most recent round was Series A. The last funding was announced in May 2025.
Stylus Medicine's investors include RA Capital Management, Eli Lilly, Khosla Ventures, Brainstorm Ventures, Tachyon Ventures.
Stylus Medicine is headquartered in Cambridge, United States.
Stylus Medicine is on a quest to create disease-treating agents for the next generation based on the groundbreaking work of its founders.
Stylus Medicine is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Stylus Medicine — Funding & Investors." VCBacked, May 12, 2025, https://www.vcbacked.co/company/stylus-medicine. Accessed July 29, 2026.
VCBacked. (2025). Stylus Medicine — Funding & Investors. Retrieved July 29, 2026, from https://www.vcbacked.co/company/stylus-medicine
{{cite web |title=Stylus Medicine — Funding & Investors |url=https://www.vcbacked.co/company/stylus-medicine |website=VCBacked |access-date=July 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated